Biostar Pharmaceuticals
Xi'an, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A commercial pharmaceutical company specializing in small molecule anti-infective drugs and API manufacturing.
Infectious Disease
Technology Platform
Focused on advanced chemical synthesis and process optimization for the manufacturing of small molecule anti-infective drugs and APIs.
Opportunities
Growing demand for affordable antibiotics and antiviral drugs in China's vast healthcare system provides a stable market.
Risk Factors
Significant regulatory risk from ongoing national volume-based procurement (VBP) policies that aggressively drive down drug prices.
Competitive Landscape
Faces intense competition and price erosion in the crowded Chinese generic anti-infectives market.